Nienke J.E. Haverkate

Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients

Yannouck F. van Lier, Mark Davids, Nienke J.E. Haverkate et al. · Science Translational Medicine · 2020 · 157 citations

Life Sciences, Immunology, Microbiology +17

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte et al. · JAMA Oncology · 2022 · 85 citations · Full text

Medicine, Immunology, Oncology +17

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk et al. · Blood Advances · 2022 · 63 citations · Full text

Medicine, Hematology, Immunology +15

CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn’s disease

Lisette Krabbendam, Balthasar A. Heesters, Chantal M. A. Kradolfer et al. · Nature Communications · 2021 · 34 citations · Full text

Life Sciences, Immunology, Pathology +17

Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease

Mette D. Hazenberg, Nienke J.E. Haverkate, Yannouck F. van Lier et al. · Blood Advances · 2019 · 33 citations · Full text

Life Sciences, Cell Biology, Immunology +17